Increase of the adenallene anti-HIV activity in cell culture using its bis(tBuSATE) phosphotriester derivative.
- 27 November 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (2) , 265-266
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pronucleotides: Toward thein vivo delivery of antiviral and anticancer nucleotidesMedicinal Research Reviews, 2000
- Novel Approaches for Designing 5-O-Ester Prodrugs of 3-Azido-2,3-dideoxythymidine (AZT).Current Medicinal Chemistry, 2000
- Design of Anti-HIV Compounds from Nucleoside to Nucleoside 5-Triphosphate Analogs. Problems and PerspectivesCurrent Pharmaceutical Design, 2000
- Phosphodiester Amidates of Allenic Nucleoside Analogues: Anti-HIV Activity and Possible Mechanism of ActionJournal of Medicinal Chemistry, 1996
- Mononucleoside Phosphotriester Derivatives with S-Acyl-2-thioethyl Bioreversible Phosphate-Protecting Groups: Intracellular Delivery of 3'-Azido-2',3'-dideoxythymidine 5'-MonophosphateJournal of Medicinal Chemistry, 1995
- Allenols Derived from Nucleic Acid Bases — A New Class of Anti-HIV Agents: Chemistry and Biological Activity1993
- Nucleic acid derived allenols. Unusual analogs of nucleosides with antiretroviral activityJournal of the American Chemical Society, 1989
- Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.Proceedings of the National Academy of Sciences, 1988